Published in Naunyn Schmiedebergs Arch Pharmacol on November 01, 1997
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science (1999) 4.31
Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci (2008) 2.52
Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci (2001) 1.78
Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci U S A (1985) 1.50
Cannabinoid self-administration in rats: sex differences and the influence of ovarian function. Br J Pharmacol (2007) 1.47
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res (2001) 1.46
Diuretic agents related to indapamide. 1. Synthesis and activity of 1-substituted 2-(4-chloro-3-sulfamoylbenzamido)isoindolines. J Med Chem (1981) 1.36
Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Psychopharmacology (Berl) (2001) 1.34
Sleep deprivation in the rat: an animal model of mania. Eur Neuropsychopharmacol (1995) 1.25
2,6-Dialkylpiperazines. V. Synthesis of 2,6-alkylpiperazine derivatives structurally related to cinnarazine. J Med Chem (1968) 1.23
Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience (1998) 1.18
Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs. J Pharmacol Exp Ther (1978) 1.17
Role of GABA(B) receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. Eur J Pharmacol (2001) 1.15
Determination of methionine enkephalin in discrete regions of rat brain. Brain Res (1977) 1.12
Localized epileptiform activity induced by murine CRF in rats. Epilepsia (1988) 1.10
Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats. Eur J Neurosci (2003) 1.08
CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats. Behav Brain Res (1999) 1.06
Thymidylate synthase structure, function and implication in drug discovery. Curr Med Chem (2005) 1.06
Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors. J Med Chem (1996) 1.04
Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones. Br J Pharmacol (2010) 1.03
Structure-based design of inhibitors specific for bacterial thymidylate synthase. Biochemistry (1999) 0.98
Detection of two endorphin-like peptides in nucleus caudatus. Neuropharmacology (1978) 0.98
Rat brain enkephalins: distribution and biosynthesis. Adv Biochem Psychopharmacol (1978) 0.97
Benzodiazepine-induced voraciousness in cats and inhibition of amphetamine-anorexia. Life Sci (1976) 0.97
Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target. Curr Med Chem (2008) 0.96
Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches. Med Res Rev (1999) 0.96
Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatum. Brain Res (1979) 0.94
Differences in the opioid system in selected brain regions of alcohol-preferring and alcohol-nonpreferring rats. Alcohol Clin Exp Res (1999) 0.92
Astroglial in vivo response to cocaine in mouse dentate gyrus: a quantitative and qualitative analysis by confocal microscopy. Neuroscience (2002) 0.91
Semicarbazide-sensitive amine oxidase: current status and perspectives. Curr Med Chem (2004) 0.90
Fidia and neuroscience. Nature (1993) 0.90
Myelographic and MRI appearances of a thoracic spinal extradural arachnoid cyst of the spine with extra- and intraspinal extension. Neuroradiology (1992) 0.89
Neurobiological mechanisms of cannabinoid addiction. Mol Cell Endocrinol (2008) 0.89
Postsynaptic receptors are not essential for dopaminergic feedback regulation. Nature (1977) 0.89
Characterization of enkephalin-like material extracted from sympathetic ganglia. Neuropharmacology (1978) 0.89
Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice. Eur J Pharmacol (1999) 0.88
Stress-induced sleep deprivation modifies corticotropin releasing factor (CRF) levels and CRF binding in rat brain and pituitary. Pharmacol Res (1997) 0.87
In vitro excitatory actions of corticotropin-releasing factor on rat colonic motility. J Auton Pharmacol (1998) 0.87
Isradipine inhibits nicotine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav (1995) 0.87
Long-term treatment with rifaximin and lactobacilli in post-diverticulitic stenoses of the colon. Riv Eur Sci Med Farmacol (1994) 0.87
Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav (1992) 0.87
Homosexual mounting behavior induced in male rats and rabbits by a tryptophan-free diet. Life Sci (1977) 0.86
Interactions between enkephalinergic and other neuronal systems. Adv Biochem Psychopharmacol (1978) 0.85
Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis. Toxicol Lett (2001) 0.85
Enkephalin in bovine adrenal gland: multiple molecular forms of [Met5]-enkephalin immunoreactive peptides. Neuropharmacology (1980) 0.85
Intravenous self-administration of gamma-hydroxybutyric acid in drug-naive mice. Eur Neuropsychopharmacol (1998) 0.84
Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs. Curr Drug Targets (2010) 0.84
Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors. J Med Chem (1999) 0.83
Sleep deprivation increases dopamine D1 receptor antagonist [3H]SCH 23390 binding and dopamine-stimulated adenylate cyclase in the rat limbic system. Neurosci Lett (1990) 0.83
Sleep deprivation decreases mu and delta opioid receptor binding in the rat limbic system. Neurosci Lett (1991) 0.83
Reciprocal antagonism between ACTH1-24 and beta-endorphin in rats. Neurosci Lett (1981) 0.82
Neonatal monosodium glutamate abolishes corticotropin-releasing factor-induced epileptogenic activity in rats. Epilepsia (1991) 0.82
Decreased content of immunoreactive enkephalin-like peptide in peripheral tissues of spontaneously hypertensive rats. Nature (1979) 0.82
Phthalein derivatives as a new tool for selectivity in thymidylate synthase inhibition. J Med Chem (1999) 0.81
The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine. Brain Res Bull (1991) 0.81
Designed multiple ligands: basic research vs clinical outcomes. Curr Med Chem (2012) 0.81
Corticotropin-releasing factor (CRF) increases paradoxical sleep (PS) rebound in PS-deprived rats. Brain Res (1990) 0.81
The opioid-receptor-like 1 (ORL-1) as a potential target for new analgesics. Eur J Med Chem (2000) 0.81
Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference paradigm. Psychopharmacology (Berl) (1997) 0.81
Dopamine D1 and opioid receptor binding changes in the limbic system of sleep deprived rats. Neurochem Int (1992) 0.81
Chronic imipramine, L-sulpiride and mianserin decrease corticotropin releasing factor levels in the rat brain. Neurosci Lett (1995) 0.81
Gamma-hydroxybutyric acid: an evaluation of its rewarding properties in rats and mice. Alcohol (2000) 0.80
Changes in dopamine metabolism associated with fasting and satiation. Adv Biochem Psychopharmacol (1977) 0.80
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects. Neuroscience (2005) 0.80
Different epileptogenic activities of murine and ovine corticotropin-releasing factor. Brain Res (1987) 0.80
Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats. Br J Pharmacol (2011) 0.80
Animal models of mania. Adv Biochem Psychopharmacol (1995) 0.80
Aphrodisiac effect of L-DOPA and apomorphine in male sexually sluggish rats. Experientia (1974) 0.79
[Partially hydrolyzed guar gum: a fiber as coadjuvant in the irritable colon syndrome]. Clin Ter (2001) 0.79
Selective ACAT inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugs. Mini Rev Med Chem (2003) 0.79
Isoxazolo-[3,4-d]-pyridazin-7-(6H)-ones and their corresponding 4,5-disubstituted-3-(2H)-pyridazinone analogues as new substrates for alpha1-adrenoceptor selective antagonists: synthesis, modeling, and binding studies. Bioorg Med Chem (1998) 0.79
Baclofen antagonises intravenous self-administration of gamma-hydroxybutyric acid in mice. Neuroreport (2001) 0.79
Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation. Br J Pharmacol (2012) 0.79
Study of the antisecretory and antiulcer mechanisms of a new indenopirydazinone derivative in rats. Pharmacol Res (1997) 0.78
The cyclo-oxygenase inhibitor nimesulide induces conditioned place preference in rats. Eur J Pharmacol (2000) 0.78
Gamma-hydroxybutyric acid decreases intravenous cocaine self-administration in rats. Pharmacol Biochem Behav (1998) 0.78
Effects of the calcium antagonist isradipine on cocaine intravenous self-administration in rats. Psychopharmacology (Berl) (1994) 0.78
Stimulation of dopamine autoreceptors elicits "premature ejaculation" in rats. Pharmacol Biochem Behav (1984) 0.78
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. J Med Chem (1998) 0.78
Dopamine and opioids interactions in sleep deprivation. Prog Neuropsychopharmacol Biol Psychiatry (1993) 0.77
Distribution of beta-endorphin and related peptides in the hypothalamus and pituitary. Neuroscience (1979) 0.77
Hypophysectomy prevents ACTH-induced yawning and penile erection in rats. Pharmacol Biochem Behav (1987) 0.77
Letter: The effect of D- and L-p-chlorophenylalanine on the metabolism of 5-hydroxytryptamine in brain. J Pharm Pharmacol (1973) 0.77
Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists. J Med Chem (2001) 0.77
Synthesis and pharmacological study of 5-aryl-6-methyl-4,5-dihydro-pyridazin-3(2H)ones and related 5-aryl-6-methyl-pyridazin-3(2H)ones. Farmaco Sci (1988) 0.77
Possible mechanism of antidepressant effect of L-sulpiride. Clin Neuropharmacol (1990) 0.77
C-Fos expression as a molecular marker in corticotropin-releasing factor-induced seizures. Synapse (1996) 0.77
Oxytocin concentration changes in different rat brain areas but not in plasma during aging. Neurobiol Aging (1993) 0.77
Lack of copulatory behaviour in male castrated rats after p-chlorophenylalanine. Br J Pharmacol (1974) 0.76
Electrocortical power spectrum changes induced by microinfusion of corticotropin-releasing factor into the locus coeruleus in rats. Funct Neurol (1993) 0.76
5,6-Diphenylpyridazine derivatives as acyl-CoA:cholesterol acyltransferase inhibitors. J Med Chem (2001) 0.76
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. Br J Pharmacol (2013) 0.75
Hypothalamic ACTH and MSH levels increase in morphine tolerance and decrease after morphine withdrawal. Eur J Pharmacol (1983) 0.75